Putnam BioRevolution ETF (SYNB)

Find here information about the Putnam BioRevolution ETF ETF (NYSE:SYNB). You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others. Looking to enhance your knowledge on the ETFs? Within our ETF guide we answer questions such as what is an ETF and 'how do ETFs work'. Visit our Investing Academy to learn more.

NYSE

Currency in USD

29.50

-0.11(-0.37%)

Closed·29/07

Day's Range

29.50

52 wk Range

24.57

33.23

Day's Range

29.5029.50

52 wk Range

24.5733.23

Key Statistics

Morning Star Rating: -
Risk Rating: -
Bid / Ask: -
Prev. Close: 29.50
Price Open: 29.50
Volume: 0
Average Vol. (3m): 304
1-Year Change: -8.70%
Day’s Range: 29.50-29.50
52-Week Range: 24.57-33.23
Market Cap: 48.81B
Expense Ratio: 0.71%

Total Assets: 4.96M
Shares Outstanding: 175.00K
Net Assets Value: 28.34
ROI (TTM): -
ROA: 4.96%
ROE: 16.25%
DTC: 35.60
Dividends (TTM): 0.2139
Dividend Yield: 0.7251%
Inception Date: Sep 29, 2022
Asset Class: Equity
Leveraged: No

Covered Call: No
Socially Responsible: -
Index Fund: No
Non-Diversified: Yes
Issuer: Franklin Templeton Investments
Underlying / Benchmark: Russell 3000 TR USD
Domicile: United States
Number of Holdings: 35
ISIN: -
Beta: 0.84

Morning Star Rating: -
Risk Rating: -
Bid / Ask: -
Prev. Close: 29.50
Price Open: 29.50
Volume: 0
Average Vol. (3m): 304
1-Year Change: -8.70%
Day’s Range: 29.50-29.50
52-Week Range: 24.57-33.23
Market Cap: 48.81B
Expense Ratio: 0.71%
Total Assets: 4.96M
Shares Outstanding: 175.00K
Net Assets Value: 28.34
ROI (TTM): -
ROA: 4.96%

ROE: 16.25%
DTC: 35.60
Dividends (TTM): 0.2139
Dividend Yield: 0.7251%
Inception Date: Sep 29, 2022
Asset Class: Equity
Leveraged: No
Covered Call: No
Socially Responsible: -
Index Fund: No
Non-Diversified: Yes
Issuer: Franklin Templeton Investments
Underlying / Benchmark: Russell 3000 TR USD
Domicile: United States
Number of Holdings: 35
ISIN: -
Beta: 0.84

How do you feel today about SYNB?

Vote to see community's results!

Technical Analysis

Summary

Strong Sell

Sell

Neutral

Buy

Strong Buy

Technical Indicators

Strong Buy

Moving Averages

Buy

Performance

Name	YTD	3M	1Y	3Y	5Y	10Y
Growth of 1000	957	1,012	915	-	-	-
Fund Return	-4.34%	+1.23%	-8.51%	-	-	-
Rank in Category	130	41	118	-	-	-
Percentile Rank	77	33	72	-	-	-

Holdings

			Upside
Thermo Fisher Scientific Inc	TMO	7.20%	aa.aa	482.16	-0.58%	881
Corteva Inc	CTVA	6.51%	aa.aa	72.88	+0.66%	4,332
Novozymes AS DRC	NVZMY	5.98%	aa.aa	67.84	-0.60%	4,140
AbbVie Inc	ABBV	5.02%	aa.aa	191.22	+1.43%	1,340
Bio-Rad Laboratories Inc	BIO	4.95%	aa.aa	252.60	-0.25%	1,018
Ascendis Pharma AS	ASND	4.41%	aa.aa	163.32	-0.51%	1,267
NVIDIA Corporation	NVDA	4.40%	aa.aa	175.51	-0.70%	1,381
AstraZeneca PLC ADR	AZN	4.15%	aa.aa	73.98	+2.99%	2,943
Eli Lilly and Company	LLY	3.91%	aa.aa	762.95	-5.59%	249
Cadence Design Systems Inc	CDNS	3.77%	aa.aa	366.26	+9.74%	607

Putnam BioRevolution ETF Company Profile

Putnam ETF Trust - Putnam BioRevolution ETF is an exchange traded fund launched and managed by Putnam Investment Management, LLC. The fund is co-managed by Putnam Investments Limited. It invests in the public equity markets of global region. It invests in stocks of companies operating across healthcare, pharmaceuticals, biotechnology, life sciences and biology revolution sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to benchmark the performance of its portfolio against the S&P 500 Index. Putnam ETF Trust - Putnam BioRevolution ETF was formed on September 29, 2022 and is domiciled in the United States.

Industry

Sector

Equity Type

ETF

Market

United States

FAQ

How is the performance of SYNB?

As of 30 Jul 2025, SYNB is trading at a price of 29.50, with a previous close of 29.50. The stock has fluctuated within a day range of 29.50 to 29.50, while its 52-week range spans from 24.57 to 33.23.

What is the current price of SYNB?

The SYNB stock price today is 29.50.

Does SYNB Pay Dividends? What’s The Current Dividend Yield?

The Putnam BioRevolution dividend yield is 0.73%.

What is the P/E ratio of SYNB?

The P/E ratio for SYNB is 20.01.

From a Technical Analysis Perspective, Is SYNB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

What is the SYNB market cap?

The market cap for SYNB is 5.16M.

NSE 30

5,095.46

+36.32

+0.72%

NSE All Share

138,904.25

+991.38

+0.72%

US 30

44,658.80

+25.8

+0.06%

US 500

6,381.40

+10.5

+0.16%

FTSE 100

9,101.40

-34.92

-0.38%

DAX

24,255.47

+57.19

+0.24%

South Africa Top 40

91,460.31

-60.43

-0.07%

Market Movers

Name	Last	Chg. %	Vol.
Fidelitybk	21.350	+4.15%	77.57M
Nigerian Breweries	75.90	+2.57%	19.52M
Guaranty Trust Holding	101.00	+3.06%	16.38M
Nascon	99.10	+7.72%	11.60M
Lafarge Africa	148.00	+5.49%	7.88M
MTN Nigeria	489.10	+8.30%	5.21M
Dangote Cement	507.30	-0.45%	2.45M

Name	Last	Chg. %	Vol.
Royalex	1.54	+10.00%	14.39M
Custodian Allied	36.30	+10.00%	101.66K
Union Dicon Salt	9.90	+10.00%	61.70K
Airtel Africa	2,541.50	+10.00%	53.00
SCOA Nigeria	5.500	+10.00%	287.40K
Dangote Sugar	71.15	+9.97%	6.25M
Berger Paints	37.50	+9.97%	1.98M

Name	Last	Chg. %	Vol.
Nahco	110.000	-5.98%	3.26M
Total Nig	634.50	-10.00%	97.44K
Geregu Power	1,027.40	-10.00%	2.08K
FTN Cocoa Processors PLC	6.30	-10.00%	9.86M
Transcorp Power	288.00	-10.00%	20.48K
Conoil	211.10	-9.98%	5.02K
Livingtrust Mortgage Bank	6.59	-9.97%	700.00

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Putnam BioRevolution ETF (SYNB)

Key Statistics

Technical Analysis

Performance

Holdings

Thermo Fisher Scientific Inc

Corteva Inc

Novozymes AS DRC

AbbVie Inc

Bio-Rad Laboratories Inc

Ascendis Pharma AS

NVIDIA Corporation

AstraZeneca PLC ADR

Eli Lilly and Company

Cadence Design Systems Inc